Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zolgensma for the Treatment of Spinal Muscular Atrophy

Drug Name

Zolgensma® (onasemnogene abeparvovec-xioi)

Developer

Avexis

Therapy Class

Gene therapy

Product Description

Adeno-associated virus vector-based gene therapy

Current Indication

Spinal muscular atrophy

Market Sector

CNS

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top